Step 1: Understanding the Question:
The question asks for the selection of a Calcium Channel Blocker (CCB) specifically used for "rate control" in a supraventricular arrhythmia (Atrial Flutter).
Step 2: Detailed Explanation:
Classification of CCBs:
- Dihydropyridines (DHP): Amlodipine, Nifedipine, Felodipine. These primarily cause vasodilation and have little to no effect on the heart's conduction system.
- Non-Dihydropyridines (Non-DHP): Diltiazem and Verapamil. These act on both the vessels and the heart.
Mechanism of Action: Non-DHP CCBs like Diltiazem work by blocking L-type calcium channels in the Sinoatrial (SA) and Atrioventricular (AV) nodes. This slows AV conduction and prolongs the refractory period.
Clinical Use in Flutter/Fibrillation: For Atrial Flutter, the goal of a CCB is to prevent a 1:1 or 2:1 conduction of rapid atrial impulses to the ventricles. By slowing the AV node, Diltiazem maintains a safe heart rate (rate control).
- DHP CCBs (A, B, D) are ineffective for arrhythmias and can cause reflex tachycardia, which might worsen the situation.
Prophylaxis: Diltiazem is often used for long-term oral rate control in patients who cannot tolerate beta-blockers.
Step 3: Final Answer:
Diltiazem is the correct choice as it is a Non-DHP CCB with significant AV nodal blocking properties.